Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2015: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Outline of Final Research Achievements |
The aim of this study is show allogeneic DCG will work stronger than syngeneic DCG in terms of anti-tumor effect in mouse lung metastasis treatment model of NKT cells that act on the innate and acquired immunity system. By introducing tumor antigen into allogeneic or syngeneic DCG, we will elucidate to generate tumor antigen-specific T cells in this system, and moreover, we will create the system to analyze the functions and sequential differentiation of them.
|